文献速递垂体与肾上腺疾病性腺与生殖内分泌肥胖与代谢综合征

大型队列中儿童脑肿瘤后早期内分泌紊乱高发

High Prevalence of Early Endocrine Disorders After Childhood Brain Tumors in a Large Cohort.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

这项非干预性观察研究基于221例在儿科内分泌科随访的原发性脑肿瘤患者的病历数据,中位诊断年龄6.7岁,中位随访6.7年。鞍上肿瘤患者甲状腺功能减退、ACTH缺乏及低促性腺激素性性腺功能减退的患病率均显著高于非鞍上肿瘤患者。作者结论认为早期内分泌紊乱发生率高,所有脑肿瘤患者均应进行内分泌咨询和营养评估。

要点

  • 鞍上肿瘤患者甲状腺功能减退患病率为76.4%,非鞍上为33.9%(P < 0.001)。
  • 鞍上肿瘤患者ACTH缺乏患病率为69.8%,非鞍上为6.1%(P < 0.001)。
  • 作者认为所有脑肿瘤患者均应进行内分泌咨询和营养评估。

核心结论

  • 儿童脑肿瘤后早期内分泌紊乱发生率高,所有脑肿瘤患者均应强制进行内分泌咨询和营养评估,尤其是鞍上肿瘤或下丘脑/垂体放疗后。

研究设计与样本

  • 非干预性观察研究,基于221例在儿科内分泌科随访的原发性脑肿瘤患者的病历数据收集。

主要发现

  • 中位诊断年龄6.7岁(范围0-15.9),中位随访6.7年(0.3-26.6),女性占48.9%。
  • 主要肿瘤类型为髓母细胞瘤(37.6%)、颅咽管瘤(29.0%)和胶质瘤(20.4%);按解剖位置,鞍上占48%,非鞍上占52%。
  • 生长激素缺乏患病率在鞍上组为83.0%、非鞍上组为76.5%,两组相似(P = 0.338),诊断后中位1.8年(-0.8至12.4)出现;放疗后生长激素缺乏在放疗后中位1.6年(0.2-10.7)出现。
  • 甲状腺功能减退在鞍上组(76.4%)比非鞍上组(33.9%)更常见(P < 0.001),ACTH缺乏亦然(鞍上69.8% vs 非鞍上6.1%;P < 0.001)。
  • 性早熟在鞍上组(16%)与非鞍上组(12.2%)相似;低促性腺激素性性腺功能减退在鞍上组(63.1%)比非鞍上组(1.3%)更常见(P < 0.001),化疗后性腺毒性在非鞍上组(29.6%)比鞍上组(2.8%)更常见(P < 0.001)。

临床怎么用

  • 作者认为所有脑肿瘤患者均应强制进行内分泌咨询和营养评估,尤其是鞍上肿瘤或下丘脑/垂体放疗后。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Endocrine complications are common in pediatric brain tumor patients. OBJECTIVE: We aimed to describe the endocrine follow-up of patients with primary brain tumors. METHODS: This is a noninterventional observational study based on data collection from medical records of 221 patients followed at a Pediatric Endocrinology Department. RESULTS: Median age at diagnosis was 6.7 years (range, 0-15.9), median follow-up 6.7 years (0.3-26.6), 48.9% female. Main tumor types were medulloblastoma (37.6%), craniopharyngioma (29.0%), and glioma (20.4%). By anatomic location, 48% were suprasellar (SS) and 52% non-suprasellar (NSS). Growth hormone deficiency (GHD) prevalence was similar in both groups (SS: 83.0%, NSS: 76.5%; P = 0.338), appearing at median 1.8 years (-0.8 to 12.4) after diagnosis; postradiotherapy GHD appeared median 1.6 years after radiotherapy (0.2-10.7). Hypothyroidism was more prevalent in SS (76.4%), than NSS (33.9%) (P < 0.001), as well as ACTH deficiency (SS: 69.8%, NSS: 6.1%; P < 0.001). Early puberty was similar in SS (16%) and NSS (12.2%). Hypogonadotropic hypogonadism was predominant in SS (63.1%) vs NSS (1.3%), P < 0.001, and postchemotherapy gonadal toxicity in NSS (29.6%) vs SS (2.8%), P < 0.001. Adult height was lower for NSS compared to target height (-1.0 SD, P < 0.0001) and to SS patients (P < 0.0001). Thyroid nodules were found in 13/45 patients (28.8%), including 4 cancers (4.8-11.5 years after radiotherapy). Last follow-up visit BMI was higher in both groups (P = 0.0001), and obesity incidence was higher for SS (46.2%) than NSS (17.4%). CONCLUSION: We found a high incidence of early-onset endocrine disorders. An endocrine consultation and nutritional evaluation should be mandatory for all patients with a brain tumor, especially when the tumor is suprasellar or after hypothalamus/pituitary irradiation.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. González Briceño LG, Kariyawasam D, Samara-Boustani D, et al. High Prevalence of Early Endocrine Disorders After Childhood Brain Tumors in a Large Cohort. J Clin Endocrinol Metab. 2022. PMID: 34918112. doi:10.1210/clinem/dgab893

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。